ABL Diagnostics (XPAR:ABLD) Total Assets : €16.37 Mil (As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Total Assets?

ABL Diagnostics's Total Assets for the quarter that ended in Jun. 2023 was €16.37 Mil.

During the past 12 months, ABL Diagnostics's average Total Assets Growth Rate was 16016.30% per year. During the past 3 years, the average Total Assets Growth Rate was 292.00% per year. During the past 5 years, the average Total Assets Growth Rate was -24.10% per year. During the past 10 years, the average Total Assets Growth Rate was -29.80% per year.

During the past 13 years, ABL Diagnostics's highest 3-Year average Total Assets Growth Rate was 292.00%. The lowest was -85.10%. And the median was -9.30%.

Total Assets is connected with ROA %. ABL Diagnostics's annualized ROA % for the quarter that ended in Jun. 2023 was -5.83%. Total Assets is also linked to Revenue through Asset Turnover. ABL Diagnostics's Asset Turnover for the quarter that ended in Jun. 2023 was 0.18.

ABL Diagnostics Total Assets Historical Data

The historical data trend for ABL Diagnostics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Total Assets Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

7.75

7.21

2.38

2.71

15.41

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial															2.73	2.71	2.63	15.41	16.37

ABL Diagnostics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

ABL Diagnostics's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	6.754	+	8.654
	=	15.41

ABL Diagnostics's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	6.711	+	9.661
	=	16.37

ABL Diagnostics (XPAR:ABLD) Total Assets Explanation

Total Assets is connected with ROA %.

ABL Diagnostics's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-0.926	/	( (15.408	+	16.372)	/ 2 )
	=	-0.926	/	15.89
	=	-5.83 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

ABL Diagnostics's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	2.876	/	( (15.408	+	16.372)	/ 2 )
=	2.876	/	15.89
=	0.18

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

ABL Diagnostics Total Assets Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines